Financial Consulate, Inc Durect Corp Transaction History

Financial Consulate, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.38 - $0.64 $9,386 - $15,808	-24,700 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$0.55 - $0.98 $13,585 - $24,206	-24,700 Reduced 50.0%	24,700 $17,000
Q1 2021 Apr 19, 2021	BUY	$1.86 - $2.87 $45,942 - $70,889	24,700 Added 100.0%	49,400 $98,000
Q1 2020 Apr 29, 2020	BUY	$0.97 - $2.85 $23,959 - $70,395	24,700 New	24,700 $38,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.